Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma
暂无分享,去创建一个
G. Morgan | A. Palumbo | P. Moreau | F. Davies | M. Delforge | T. Facon | J. Bladé | R. García Sanz | M. Kropff | S. Schey | F. Costa